Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC11H11ClN6O2 |
InChIKeyNOGLUAGKODIFPO-UHFFFAOYSA-N |
CAS Registry587009-68-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 25 Feb 2013 |